Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
Department of Pulmonology, Maastricht University Medical Center, Maastricht, The Netherlands.
J Allergy Clin Immunol. 2018 Aug;142(2):435-450.e10. doi: 10.1016/j.jaci.2017.08.043. Epub 2017 Nov 3.
Emerging studies suggest that enhanced glycolysis accompanies inflammatory responses. Virtually nothing is known about the relevance of glycolysis in patients with allergic asthma.
We sought to determine whether glycolysis is altered in patients with allergic asthma and to address its importance in the pathogenesis of allergic asthma.
We examined alterations in glycolysis in sputum samples from asthmatic patients and primary human nasal cells and used murine models of allergic asthma, as well as primary mouse tracheal epithelial cells, to evaluate the relevance of glycolysis.
In a murine model of allergic asthma, glycolysis was induced in the lungs in an IL-1-dependent manner. Furthermore, administration of IL-1β into the airways stimulated lactate production and expression of glycolytic enzymes, with notable expression of lactate dehydrogenase A occurring in the airway epithelium. Indeed, exposure of mouse tracheal epithelial cells to IL-1β or IL-1α resulted in increased glycolytic flux, glucose use, expression of glycolysis genes, and lactate production. Enhanced glycolysis was required for IL-1β- or IL-1α-mediated proinflammatory responses and the stimulatory effects of IL-1β on house dust mite (HDM)-induced release of thymic stromal lymphopoietin and GM-CSF from tracheal epithelial cells. Inhibitor of κB kinase ε was downstream of HDM or IL-1β and required for HDM-induced glycolysis and pathogenesis of allergic airways disease. Small interfering RNA ablation of lactate dehydrogenase A attenuated HDM-induced increases in lactate levels and attenuated HDM-induced disease. Primary nasal epithelial cells from asthmatic patients intrinsically produced more lactate compared with cells from healthy subjects. Lactate content was significantly higher in sputum supernatants from asthmatic patients, notably those with greater than 61% neutrophils. A positive correlation was observed between sputum lactate and IL-1β levels, and lactate content correlated negatively with lung function.
Collectively, these findings demonstrate that IL-1β/inhibitory κB kinase ε signaling plays an important role in HDM-induced glycolysis and pathogenesis of allergic airways disease.
新的研究表明,糖酵解伴随着炎症反应而增强。实际上,人们对过敏性哮喘患者的糖酵解过程知之甚少。
我们旨在确定糖酵解是否在过敏性哮喘患者中发生改变,并探讨其在过敏性哮喘发病机制中的重要性。
我们检测了哮喘患者痰样本和原代人鼻细胞中糖酵解的变化,并使用过敏性哮喘的小鼠模型以及原代小鼠气管上皮细胞来评估糖酵解的相关性。
在过敏性哮喘的小鼠模型中,IL-1 依赖性地诱导了肺部的糖酵解。此外,气道内给予 IL-1β刺激了乳酸的产生和糖酵解酶的表达,气道上皮细胞中明显表达了乳酸脱氢酶 A。实际上,IL-1β或 IL-1α 暴露于小鼠气管上皮细胞中导致糖酵解通量、葡萄糖利用、糖酵解基因表达和乳酸产生增加。增强的糖酵解对于 IL-1β 或 IL-1α 介导的促炎反应以及 IL-1β 对尘螨(HDM)诱导的胸腺基质淋巴细胞生成素和 GM-CSF 从气管上皮细胞释放的刺激作用是必需的。HDM 或 IL-1β 下游的 IκB 激酶 ε 对于 HDM 诱导的糖酵解和过敏性气道疾病的发病机制是必需的。乳酸脱氢酶 A 的小干扰 RNA 消融减弱了 HDM 诱导的乳酸水平升高,并减弱了 HDM 诱导的疾病。与健康受试者的细胞相比,哮喘患者的原代鼻上皮细胞本身产生更多的乳酸。哮喘患者的痰上清液中乳酸含量明显较高,特别是中性粒细胞大于 61%的患者。痰乳酸与 IL-1β 水平之间存在正相关,乳酸含量与肺功能呈负相关。
总之,这些发现表明,IL-1β/IκB 激酶 ε 信号通路在 HDM 诱导的糖酵解和过敏性气道疾病的发病机制中起着重要作用。